Article

Ophthalmogenetic testing available from Asper Ophthalmics

Asper Ophthalmics continues to work on the development of new genetic tests for numerous ophthalmologic diseases. Among these are ABCR genetic testing, Usher syndrome testing, Leber congenital amaurosis (LCA) genetic testing, autosomal recessive retinitis pigmentosa (AR-RP) genetic testing, autosomal dominant retinitis pigmentosa (AD-RP) genetic testing, and Bardet Biedl syndrome (BBS) genetic testing.

Asper Ophthalmics continues to work on the development of new genetic tests for numerous ophthalmologic diseases.

Among these are ABCR genetic testing, Usher syndrome testing, Leber congenital amaurosis (LCA) genetic testing, autosomal recessive retinitis pigmentosa (AR-RP) genetic testing, autosomal dominant retinitis pigmentosa (AD-RP) genetic testing, and Bardet Biedl syndrome (BBS) genetic testing.

In addition, the company said it has plans to introduce several new tests this year and update existing tests. New tests will be launched for screening of genetic variations related to Best's disease and congenital stationary night blindness. Both tests will cover approximately 100 mutations. Other testing will be available soon for X-linked retinitis pigmentosa, autosomal dominant optic atrophy, and corneal diseases.

For more information, visit Asper Ophthalmics at Booth 800.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
© 2025 MJH Life Sciences

All rights reserved.